A2A Receptor Intervention Protects Astrocytes Against 6-Hydroxydopamine-Induced Oxidative and Mitochondrial Stress via the p38 MAPK Axis, Alleviating Inflammation in an In Vivo Model of Parkinson's Disease.
Medicine